Henry Schein

Also known as: Henry Schein, Inc., Global Oral Reconstruction Group, BioHorizons Camlog Group

The Nasdaq-listed healthcare distributor that also manufactures dental implants: its Global Oral Reconstruction Group owns the BioHorizons and Camlog implant brands.

Key facts

Headquarters	Melville, New York, United StatesVerified spec[1]
Country	United StatesVerified spec[1]
Founded	Manufacturer documentation not located(We have not attached a primary source for the founding date of Henry Schein, Inc.)
Ownership	Publicly listed. Common stock trades on the Nasdaq stock market under the ticker HSICVerified spec[1]
Brand	Implant brands: BioHorizons and Camlog, operated together as the BioHorizons Camlog Group, which also lists the Brazilian SIN implant systemVerified spec[2][3][1]
Current status	BioHorizons was acquired by Henry Schein in 2014; implants sit within the Global Oral Reconstruction Group, part of the Global Specialty Products segment, which manufactures in the United States, Switzerland, Germany, Brazil and FranceVerified spec[1][3]Camlog’s own site names the division "Global Dental Surgical Group"; Henry Schein and BioHorizons use "Global Oral Reconstruction Group". The two names appear to describe the same organisation.

Overview

Henry Schein is best known as a distributor, which obscures the fact that it is also an implant manufacturer — and that BioHorizons and Camlog still share the same owner. It took a majority position in BioHorizons in stages from 2013 and completed the acquisition in 2014, having already owned Camlog, and since 2016 has run them jointly; the combined organisation now trades as the BioHorizons Camlog Group from Basel. The two brands were deliberately not merged into one product line, so a BioHorizons implant and a Camlog implant remain different systems with different connections and different components. Henry Schein’s 2025 annual filing still records implants as a manufacturing activity across sites in the United States, Switzerland, Germany, Brazil and France, so the ownership arrangement remains current.

Regulatory record

Read this before drawing conclusions. A clearance or certificate means a device may legally be sold in a market. It is not a finding that the implant performs well, and it is not a comparison against other implants. In particular, FDA "clearance" is not FDA "approval" — clearance means the FDA accepted the device as substantially equivalent to one already on the market. What these actually mean →

Other1 record

Of 10 records we inspected, 0 are supplied sterile, 10 are supplied non-sterile and 0 do not state it. MRI safety labelling: Labeling does not contain MRI Safety Information (10). A UDI listing records what the manufacturer declared about the device; it is not a clearance or an approval.

Number	Device	Holder	Date
5 device records	—	Henry Schein	—

Clearance records for Henry Schein were retrieved from the issuing authority's own database, not from the manufacturer's marketing material. We attribute a clearance to a brand only when the filing holder belongs to that brand's corporate family — third-party clearances for compatible components are excluded, because they belong to the company that made the component, not to Henry Schein.

Sources

Numbers match the citations beside each claim above.

Primary sources

[1]Henry Schein, Inc. — Annual Report on Form 10-K for the year ended 27 December 2025 — U.S. Securities and Exchange Commission (EDGAR), 2026. Accessed 2026-07-21.
[2]Brands of BioHorizons Camlog Group — BioHorizons Camlog Group. Accessed 2026-07-21.
[3]Premium Dental Implant Systems from BioHorizons and Camlog — BioHorizons, Inc.. Accessed 2026-07-21.